LD medical: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LD medical
Largest movements
- Cash +€477,760
up €477,760 (+450%), from €106,253 to €584,014
mainly Current investments (+€363,867) and Net result for the year (+€236,677)
- Current investments -€363,867
down €363,867 (-28.8%), from €1.3m to €900,112
- Receivables within one year -€29,319
down €29,319 (-20.4%), from €143,872 to €114,553
of which Other amounts receivable: -€20,625
- Reserves +€236,677
up €236,677 (+19.8%), from €1.2m to €1.4m
of which Distributable reserves: +€139,135
- Other debts -€209,613
down €209,613 (-70.5%), from €297,313 to €87,700
- Tax, wage and social debts +€49,092
up €49,092 (+191%), from €25,655 to €74,747
- Taxes +€29,242
up €29,242 (+28.6%), from €102,310 to €131,551
- Financial charges -€18,052
down €18,052, from €4,418 to -€13,634
- Financial income -€5,367
down €5,367 (-11.3%), from €47,420 to €42,053
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,533,087 | €1,609,503 | +€76,416 | +5.0% |
| Fixed assets | 21/28 | €10,492 | €7,816 | -€2,675 | -25.5% |
| Tangible fixed assets | 22/27 | €10,192 | €7,516 | -€2,675 | -26.3% |
| Furniture and vehicles | 24 | €7,700 | €6,419 | -€1,281 | -16.6% |
| Other tangible fixed assets | 26 | €2,492 | €1,097 | -€1,394 | -56.0% |
| Financial fixed assets | 28 | €300 | €300 | = | 0.0% |
| Current assets | 29/58 | €1,522,596 | €1,601,687 | +€79,091 | +5.2% |
| Amounts receivable within one year | 40/41 | €143,872 | €114,553 | -€29,319 | -20.4% |
| Trade receivables | 40 | €123,247 | €114,553 | -€8,694 | -7.1% |
| Other amounts receivable | 41 | €20,625 | €0 | -€20,625 | -100% |
| Current investments | 50/53 | €1,263,979 | €900,112 | -€363,867 | -28.8% |
| Cash at bank and in hand | 54/58 | €106,253 | €584,014 | +€477,760 | +450% |
| Deferred charges and accrued income | 490/1 | €8,491 | €3,008 | -€5,483 | -64.6% |
| Total equity and liabilities | 10/49 | €1,533,087 | €1,609,503 | +€76,416 | +5.0% |
| Equity | 10/15 | €1,208,845 | €1,445,523 | +€236,677 | +19.6% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €1,195,398 | €1,432,076 | +€236,677 | +19.8% |
| Non-distributable reserves | 130/1 | €14,865 | €0 | -€14,865 | -100% |
| Reserves not available under the articles | 1311 | €14,865 | €0 | -€14,865 | -100% |
| Tax-exempt reserves | 132 | €234,076 | €346,483 | +€112,407 | +48.0% |
| Distributable reserves | 133 | €946,457 | €1,085,593 | +€139,135 | +14.7% |
| Profit (loss) carried forward | 14 | €1,047 | €1,047 | = | 0.0% |
| Amounts payable | 17/49 | €324,242 | €163,980 | -€160,262 | -49.4% |
| Amounts payable within one year | 42/48 | €324,242 | €163,980 | -€160,262 | -49.4% |
| Trade debts | 44 | €1,273 | €1,533 | +€259 | +20.3% |
| Suppliers | 440/4 | €1,273 | €1,533 | +€259 | +20.3% |
| Taxes, remuneration and social security | 45 | €25,655 | €74,747 | +€49,092 | +191% |
| Taxes | 450/3 | €25,655 | €74,747 | +€49,092 | +191% |
| Other amounts payable | 47/48 | €297,313 | €87,700 | -€209,613 | -70.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,720 | €3,097 | +€377 | +13.9% |
| Other operating charges | 640/8 | €2,098 | €1,969 | -€129 | -6.1% |
| Gross operating margin | 9900 | €319,297 | €317,609 | -€1,688 | -0.5% |
| Operating profit (loss) | 9901 | €314,479 | €312,542 | -€1,937 | -0.6% |
| Financial income | 75/76B | €47,420 | €42,053 | -€5,367 | -11.3% |
| Recurring financial income | 75 | €47,420 | €42,053 | -€5,367 | -11.3% |
| Financial charges | 65/66B | €4,418 | -€13,634 | -€18,052 | |
| Recurring financial charges | 65 | €4,418 | -€13,634 | -€18,052 | |
| Profit (loss) for the period before taxes | 9903 | €357,481 | €368,229 | +€10,748 | +3.0% |
| Income taxes | 67/77 | €102,310 | €131,551 | +€29,242 | +28.6% |
| Profit (loss) for the period | 9904 | €255,171 | €236,677 | -€18,494 | -7.2% |
| Transfer to tax-exempt reserves | 689 | €112,407 | €112,407 | = | 0.0% |
| Profit (loss) for the period to be appropriated | 9905 | €142,764 | €124,270 | -€18,494 | -13.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.